![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » PALADIN LABS TO ACQUIRE CANADIAN LICENSE TO PENNSAID
PALADIN LABS TO ACQUIRE CANADIAN LICENSE TO PENNSAID
Paladin Labs Inc. (TSX:PLB), a Canadian speciality pharmaceutical company, has acquired Dimethaid Health Care Ltd. (DHCL), a subsidiary of Dimethaid Research Inc. (TSX:DMX). DHCL owns the Canadian license for Pennsaid(R), a lotion approved by Health Canada for the treatment of symptoms of knee osteoarthritis. In return for its ownership of DHCL, Dimethaid Research has received an up-front payment, a share in operating profits above minimum targets and a long-term supply agreement.
CCN Matthews (http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&actionFor=552217)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct